Exeltis USA, Inc.
10 drugs in NADAC|0 Generic,10 Brand
Exeltis USA, Inc. lists 10 NDCs in the CMS NADAC file (0 generic, 10 brand), at an average NADAC of $7.79 per unit, with a week-over-week move of -0.1% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
10
0G / 10B
Avg Price / Unit
$7.7871
$0.83 – $43.03
Avg 7d Change
-0.07%
Across 6 drugs with changes
7d Activity
of 10 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Drospirenone market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Vitamin B12 therapeutic class
Review the broader class where Exeltis USA, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Exeltis USA, Inc. make?
Exeltis USA, Inc. lists 10 NDCs in the CMS NADAC file — 0 generic and 10 brand products.
What is the average price of Exeltis USA, Inc. drugs?
The average NADAC across Exeltis USA, Inc.'s portfolio is $7.7871 per unit, ranging from $0.8277 to $43.0273.
What types of drugs does Exeltis USA, Inc. make?
Exeltis USA, Inc. makes drugs across 13 FDA pharmacologic classes. The most common by NDC count are Vitamin B12 (4), Vitamin B6 Analog (4), Vitamin C (4), Vitamin D (4), Calculi Dissolution Agent (3).
Has Exeltis USA, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Exeltis USA, Inc. in the openFDA feed.
How has Exeltis USA, Inc.'s pricing changed recently?
Over the past 7 days, 2 Exeltis USA, Inc. products rose and 4 fell, with a portfolio-wide average change of -0.1%.